Salt-induced hypertension in Dahl salt-resistant and salt-sensitive rats with NOS II inhibition

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 277, Issue 2 46-2, 1999, Pages

  Rudd, M Audrey ^a   Trolliet, Maria ^a   Hope, Susan ^a   Scribner, Anne Ward ^a   Daumerie, Geraldine ^a   Toolan, George ^a   Cloutier, Timothy ^a   Loscalzo, Joseph ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2 amino 5,6 dihydro 6 methyl 4H 1,3 thiazine; Dahl rats; N(G) nitro L arginine methyl ester; N 3 (aminomethyl)benzyl acetamidine hydrochloride; Salt sensitive hypertension

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SODIUM CHLORIDE;

ARTERY ENDOTHELIUM; ARTICLE; CHEMOSENSITIVITY; ENZYME INHIBITION; HYPERTENSION; MALE; MESENTERIC ARTERY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE;

EID: 0032831472     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.277.2.h732     Document Type: Article

References (57)

1. Ahn, K., M. Mohaupt, K. Madsen, and B. Kone. In situ localization of mRNA encoding inducible nitric oxide in the normal kidney. Am. J. Physiol. 267 (Renal Fluid Electrolyte Physiol. 36): F748-F757, 1994.
2. Bachmann, S., and P. Mundel. Nitric oxide in the kidney: synthesis, localization, and function. Am. J. Kidney Dis. 24: 112-129, 1994.
3. Banting, J., P. Friberg, and M. Adams. Acute hypertension after nitric oxide synthesis inhibition is mediated primarily by increased endothelin vasoconstriction. J. Hypertens. 14: 975-981, 1996.
4. Bryant, C., A. Tomlinson, J. Mitchell, C. Thiemermann, and D. Willoughby. Nitric oxide synthase in rat fallopian tube is regulated during the oestrous cycle. J. Endocrinol. 146: 149-157, 1995.
5. Chen, P. Y., and P. W. Sanders. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J. Clin. Invest. 88: 1559-1567, 1991.
6. Chen, P. Y., and P. W. Sanders. Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. Hypertension 22: 812-818, 1993.
7. Chen, P. Y., and P. W. Sanders. Inducible nitric oxide (NO) synthesis is impaired in aortic smooth muscle cells (ASMC) of Dahl/Rapp salt-sensitive (SS/Jr) rats (Abstract). J. Investig. Med. 43: 211A, 1995.
8. Dahl, L., M. Heine, and K. Thompson. Genetic influence of the kidneys on blood pressure. Evidence from chronic renal homografts in rats with opposite predispositions to hypertension. Circ. Res. 34: 94-101, 1974.
9. Deng, A. Y. Is the nitric oxide system involved in genetic hypertension in Dahl rats? Kidney Int. 53: 1501-1511, 1998.
10. Fernandez-Riva, A., J. Garcia-Estan, and F. Vargas. Effects of chronic increased salt intake on nitric oxide synthesis inhibition-induced hypertension. J. Hypertens. 13: 123-128, 1995.
11. Gabbai, F., G. Garcia, R. Blantz, and L. Nicola. Role of nitric oxide in glomerular physiology and pathophysiology. Adv. Nephrol. Necker Hosp. 24: 3-18, 1995.
12. Gabbai, F., S. Thomson, O. Peterson, L. Wead, K. Malvey, and R. Blantz. Glomerular and tubular interactions between renal adrenergic activity and nitric oxide. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F1004-F1008, 1995.
13. Garvey, E., J. Oplinger, E. Furfine, J. Rachel, F. Laszlo, B. Whittle, and R. Knowles. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 272: 4959-4963, 1997.
14. Garvey, E., J. Oplinger, G. Tanoury, P. Sherman, M. Fowler, S. Maeshall, M. Harmon, J. Paith, and E. Furfine. Potent and selective inhibition of human nitric oxide synthases. J. Biol. Chem. 269: 26669-26676, 1994.
15. +-ATPase by nitric oxide in mouse proximal tubule epithelial cells. J. Clin. Invest. 95: 2083-2088, 1995.
16. Haynes, W. G., M. F. Hand, M. E. C. Dockrell, D. W. Eadington, M. R. Lee, Z. Hussein, N. Benjamin, and D. J. Webb. Physiological role of nitric oxide in regulation of renal function. Am. J. Physiol. 272 (Renal Physiol. 41): F364-F371, 1997.
17. Hevel, J., and M. Marletta. Nitric oxide synthase assays. Methods Enzymol. 233: 250-269, 1994.
18. Hinko, A., M. Thibonnier, and J. Rapp. Binding characteristics of atrial natriuretic factor and the production of cyclic GMP in kidneys of Dahl salt-sensitive and salt-resistant rats. Biochem. Biophys. Res. Commun. 144: 1076-1083, 1987.
19. Hirawa, N., Y. Uehara, Y. Kawabata, A. Numabe, N. Oshima, H. Ono, T. Gomi, T. Ikeda, S. Yagi, T. Toyoaka, and M. Omata. Subpressor dose of angiotensin II increases susceptibility to the haemodynamic injury of blood pressure in Dahl salt-sensitive rats. J. Hypertens. 13: 81-90, 1995.
20. Johnson, R., and R. Freeman. Renin release in rats during blockade of nitric oxide synthesis. Am. J. Physiol. 266 (Regulatory Integrative Comp. Physiol. 35): R1723-R1729, 1994.
21. Kato, J., T. Misko, and M. Currie. Induction of nitric oxide synthase regulates atrial natriuretic peptide receptors in vascular smooth muscle cells. Eur. J. Pharmacol. 244: 153-159, 1993.
22. Kone, B. C., and C. Baylis. Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am. J. Physiol. 272 (Renal Physiol. 41): F561-F578, 1997.
23. Kvetnansky, R., K. Pacak, D. Tokarev, J. Jelokova, D. Jezova, and M. Rusnak. Chronic blockade of nitric oxide synthesis elevated plasma levels of catecholamines and their metabolites at rest and during stress in rats. Neurochem. Res. 22: 995-1001, 1997.
24. Lahera, V., J. Navarro-Cid, V. Cachofiero, J. Garca-Esta, and L. M. Ruilope. Nitric oxide, the kidney, and hypertension. Am. J. Hypertens. 10: 129-140, 1997.
25. Lahera, V., J. Salazar, M. G. Salom, and J. C. Romero. Deficient production of nitric oxide induces volume-dependent hypertension. J. Hypertens. 10: S173-S177, 1992.
26. G-nitro-L-arginine methyl ester on atrial natrial natruretic peptide and brain natriuretic peptide release. Endocrinology 136: 1241-1249, 1995.
27. Limas, C., and C. Limas. Up-regulation of renal prostaglandin receptors in genetic salt-dependent hypertension. Hypertension 8: 566-571, 1986.
28. Liu, S., I. Adcock, R. Old, P. Barnes, and T. Evans. Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA. Biochem. Biophys. Res. Commun. 196: 1208-1213, 1993.
29. Mattson, D. L., and D. J. Higgins. Influence of dietary sodium intake on renal medullary nitric oxide synthase. Hypertension 27: 688-692, 1996.
30. Mattson, D., S. Lu, K. Nakanishi, P. Papanek, and A. Cowley, Jr. Effect of chronic renal medullary nitric oxide inhibition on blood pressure. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H1918-H1926, 1994.
31. McKee, M., C. Scavone, and J. A. Nathanson. Nitric oxide, cGMP, and hormone regulation of active sodium transport. Proc. Natl. Acad. Sci. USA 91: 12056-12060, 1994.
32. Melo, L., and H. Sonnenberg. Effect of nitric oxide inhibition on secretion of atrial natriuretic factor in isolated rat heart. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H306-H311, 1996.
33. Mohaupt, M. G., J. L. Elzie, K. Y. Ahn, W. L. Clapp, C. S. Wilcox, and B. C. Kone. Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidney. Kidney Int. 46: 653-665, 1994.
34. G-nitro arginine (L-NOARG), a novel L-arginine-reversible inhibitor of endothelium-dependent vasodilation in vitro. Br. J. Pharmacol. 99: 408-412, 1990.
35. Morrissey, J. J., R. McCracken, H. Kaneto, M. Vehaskari, D. Montani, and S. Klahr. Location of an inducible nitric oxide synthase mRNA in the normal kidney. Kidney Int. 45: 998-1005, 1994.
36. Morton, J., E. Beattie, A. Speirs, and F. Gulliver. Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy. J. Hypertens. 11: 1083-1088, 1993.
37. Nakane, M., V. Klinghofer, J. E. Kuk, J. L. Donnelly, G. P. Budzik, J. S. Pollock, F. Basha, and G. W. Carter. Novel potent and selective inhibitors of inducible nitric oxide synthase. Mol. Pharmacol. 47: 831-834, 1995.
38. Navarro, J., A. Sanchez, J. Saiz, L. M. Ruilope, J. Garcia-Estan, J. C. Romero, S. Moncada, and V. Lahera. Hormonal, renal, and metabolic alterations during hypertension induced by chronic inhibition of NO in rats. Am. J. Physiol. 267 (Regulatory Integrative Comp. Physiol. 36): R1516-R1521, 1994.
39. Ono, H., Y. Ono, and E. Frohlich. ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats. Hypertension 27: 176-183, 1996.
40. Pollock, D. M., J. S. Polakowski, B. J. Divish, and T. J. Opgenorth. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension 21: 660-666, 1993.
41. Rairigh, R. L., T. D. Le Cras, D. D. Ivy, J. Kinsella, G. Richter, M. P. Horan, I. D. Fan, and S. H. Abman. Role of inducible nitric oxide synthase in regulation of pulmonary vascular tone in the late gestation ovine fetus. J. Clin. Invest. 101: 15-21, 1998.
42. Robeiro, M. O., E. Antunes, G. de Nucci, S. M. Lovisolo, and R. Zatz. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 20: 298-303, 1992.
43. Salazar, F. J., A. Alberola, J. M. Pinilla, J. C. Romero, and T. Quesada. Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition. Hypertension 22: 49-55, 1993.
44. Salvemini, D., T. P. Misko, J. L. Masferrer, K. Siebert, M. Currie, and P. Needleman. Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA 90: 7240-7244, 1993.
45. Schnackenberg, C., F. Wilkins, and J. Granger. Role of nitric oxide in modulating the vasoconstrictor actions of angiotensin II in preglomerular vessels in dogs. Hypertension 26: 1024-1029 1995.
46. Shultz, P. J., and J. P. Tolins. Adaptation to increase dietary salt intake in the rat: role of endogenous nitric oxide. J. Clin. Invest. 91: 642-650, 1993.
47. Simchon, S., W. Manger, G. Blumberg, J. Brensilver, and S. Cortell. Impaired renal vasodilation and urinary cGMP excretion in Dahl salt-sensitive rats. Hypertension 27: 653-657, 1996.
48. Singh, I., M. Grams, A. Smart, J. Schnermann, and J. Briggs. Coordinate regulation of the renin-angiotensin system and nitric oxide synthase by dietary salt (Abstract). Circulation 43: 239A, 1994.
49. Takemoto, M., K. Egashira, M. Usui, K. Numaguchi, H. Tomita, H. Tsutsui, H. Shimokawa, K. Sueishi, and A. Takeshita. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J. Clin. Invest. 99: 278-287, 1997.
50. Thompson, A., C. Valeri, and W. Lieberthal. Endothelin receptor A blockade alters hemodynamic response to nitric oxide inhibition in rats. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H743-H748, 1995.
51. Tracey, W. R., M. Nakane, F. Basha, and G. Carter. In vivo pharmacological evaluation of two novel type II (inducible) nitric oxide synthase inhibitors. Can. J. Physiol. Pharmacol. 73: 665-669, 1995.
52. Ujiie, K., J. Yuen, L. Hogarth, R. Danziger, and R. A. Star. Localization and regulation of endothelial NO synthase mRNA expression in rat kidney. Am. J. Physiol. 267 (Renal Fluid Electrolyte Physiol. 36): F296-F302, 1994.
53. Welch, W. J., and C. S. Wilcox. Role of nitric oxide in tubuloglomerular feedback: effects of dietary salt. Clin. Exp. Pharmacol. Physiol. 24: 582-586, 1997.
54. Wilcox, C. S., and W. J. Welch. TGF and nitric oxide: effects of salt intake and salt-sensitive hypertension. Kidney Int. Suppl. 49: S-9-S-13, 1996.
55. Worrall, N., T. Misko, P. Sullivan, J. Hui, C. Rodi, and T. J. Ferguson. Corticosteroids inhibit expression of inducible nitric oxide synthase during acute cardiac allograft rejection. Transplantation 61: 324-328, 1996.
56. Yamada, S. S., A. Sassaki, C. K. Fujihara, D. Malheiros, G. de Nucci, and R. Zatz. Effect of salt intake and inhibitor dose on arterial hypertension and renal injury induced by chronic nitric oxide blockade. Hypertension 27: 1165-1172, 1996.
57. G-nitroarginine, in dogs. Am. J. Hypertens. 5: 484-487, 1992.